CLDN18 and cancer: The binding of clones 2, 5, and 9 was also examined using HEK293 + CLDN18.2_M149L, a naturally occurring coding single-nucleotide polymorphism that is present in a small percentage of patients with CLDN18.2-positive cancer (42).